Detalhe da pesquisa
1.
Strengthen scientific review of research protocols.
Nature
; 617(7959): 35, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37130932
2.
Factor Analysis in Distinguishing Coronavirus Disease 2019 From Other Influenza-like Illness Using a Validated Patient-Reported Outcome Instrument FLU-PRO Plus: A Prospective Real-world Cohort Study.
Med Care
; 61(5): 288-294, 2023 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36917774
3.
Content validity and psychometric properties of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus©) instrument in patients with COVID-19.
Qual Life Res
; 32(6): 1645-1657, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-36703019
4.
Systematic surveillance of patient-reported symptoms of viral respiratory tract infectious Syndromes in diverse populations.
BMC Health Serv Res
; 22(1): 1591, 2022 Dec 29.
Artigo
Inglês
| MEDLINE | ID: mdl-36581932
5.
Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020.
Ann Intern Med
; 174(9): 1240-1251, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34224257
6.
Pharmacoepidemiology of Ceftazidime-Avibactam Use: A Retrospective Cohort Analysis of 210 US Hospitals.
Clin Infect Dis
; 72(4): 611-621, 2021 02 16.
Artigo
Inglês
| MEDLINE | ID: mdl-32107536
7.
Different epidemiological profiles in patients with Zika and dengue infection in Tapachula, Chiapas in Mexico (2016-2018): an observational, prospective cohort study.
BMC Infect Dis
; 21(1): 881, 2021 Aug 28.
Artigo
Inglês
| MEDLINE | ID: mdl-34454432
8.
Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers.
BMC Infect Dis
; 21(1): 544, 2021 Jun 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34107889
9.
Evaluation of Efficacy Endpoints for a Phase IIb Study of a Respiratory Syncytial Virus Vaccine in Older Adults Using Patient-Reported Outcomes With Laboratory Confirmation.
Value Health
; 23(2): 227-235, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32113628
10.
Evidence-Based Study Design for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia.
J Infect Dis
; 219(10): 1536-1544, 2019 04 19.
Artigo
Inglês
| MEDLINE | ID: mdl-30649434
11.
Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents.
Clin Infect Dis
; 67(12): 1803-1814, 2018 11 28.
Artigo
Inglês
| MEDLINE | ID: mdl-30052813
12.
Reliability, Validity, and Responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) Scores in Influenza-Positive Patients.
Value Health
; 21(2): 210-218, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29477403
13.
Using the Influenza Patient-reported Outcome (FLU-PRO) diary to evaluate symptoms of influenza viral infection in a healthy human challenge model.
BMC Infect Dis
; 18(1): 353, 2018 07 28.
Artigo
Inglês
| MEDLINE | ID: mdl-30055573
14.
Correction: Systematic surveillance of patient-reported symptoms of viral respiratory tract infectious Syndromes in diverse populations.
BMC Health Serv Res
; 23(1): 90, 2023 Jan 26.
Artigo
Inglês
| MEDLINE | ID: mdl-36703190
15.
Cefiderocol and the Need for Higher-Quality Evidence: Methods Matter for Patients.
Antimicrob Agents Chemother
; 66(8): e0076622, 2022 08 16.
Artigo
Inglês
| MEDLINE | ID: mdl-35862749
16.
Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force.
Value Health
; 20(1): 2-14, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28212963
17.
A systematic approach for studying the signs and symptoms of fever in adult patients: the fever assessment tool (FAST).
Health Qual Life Outcomes
; 15(1): 84, 2017 Apr 27.
Artigo
Inglês
| MEDLINE | ID: mdl-28449675
18.
Analysis of an ordinal endpoint for use in evaluating treatments for severe influenza requiring hospitalization.
Clin Trials
; 14(3): 264-276, 2017 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-28397569
19.
Progress in the Fight Against Multidrug-Resistant Bacteria? A Review of U.S. Food and Drug Administration-Approved Antibiotics, 2010-2015.
Ann Intern Med
; 165(5): 363-72, 2016 09 06.
Artigo
Inglês
| MEDLINE | ID: mdl-27239977
20.
The Wrong Cure: Financial Incentives for Unimpressive New Antibiotics.
J Infect Dis
; 223(9): 1506-1509, 2021 05 20.
Artigo
Inglês
| MEDLINE | ID: mdl-32827433